JP2013501055A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013501055A5 JP2013501055A5 JP2012523678A JP2012523678A JP2013501055A5 JP 2013501055 A5 JP2013501055 A5 JP 2013501055A5 JP 2012523678 A JP2012523678 A JP 2012523678A JP 2012523678 A JP2012523678 A JP 2012523678A JP 2013501055 A5 JP2013501055 A5 JP 2013501055A5
- Authority
- JP
- Japan
- Prior art keywords
- substituted
- unsubstituted
- alkyl
- alkenyl
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23093209P | 2009-08-03 | 2009-08-03 | |
| US61/230,932 | 2009-08-03 | ||
| US23288309P | 2009-08-11 | 2009-08-11 | |
| US61/232,883 | 2009-08-11 | ||
| PCT/US2010/044078 WO2011017249A1 (en) | 2009-08-03 | 2010-08-02 | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013501055A JP2013501055A (ja) | 2013-01-10 |
| JP2013501055A5 true JP2013501055A5 (enExample) | 2013-09-05 |
| JP5859964B2 JP5859964B2 (ja) | 2016-02-16 |
Family
ID=42782224
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012523678A Expired - Fee Related JP5859964B2 (ja) | 2009-08-03 | 2010-08-02 | 抗増殖性化合物、その抱合体、そのための方法ならびにその使用 |
Country Status (28)
| Country | Link |
|---|---|
| US (6) | US8394922B2 (enExample) |
| EP (1) | EP2461830B1 (enExample) |
| JP (1) | JP5859964B2 (enExample) |
| KR (1) | KR101759359B1 (enExample) |
| CN (2) | CN102725001B (enExample) |
| AR (1) | AR077701A1 (enExample) |
| AU (1) | AU2010279674B2 (enExample) |
| BR (1) | BR112012002615A2 (enExample) |
| CA (1) | CA2770042C (enExample) |
| CL (1) | CL2012000302A1 (enExample) |
| CO (1) | CO6501196A2 (enExample) |
| DK (1) | DK2461830T3 (enExample) |
| EA (1) | EA022288B1 (enExample) |
| ES (1) | ES2525351T3 (enExample) |
| HR (1) | HRP20140976T1 (enExample) |
| HU (1) | HUE026997T2 (enExample) |
| IL (1) | IL217717A (enExample) |
| IN (1) | IN2012DN00860A (enExample) |
| MX (1) | MX2012001665A (enExample) |
| NZ (1) | NZ597985A (enExample) |
| PE (1) | PE20121087A1 (enExample) |
| PL (1) | PL2461830T3 (enExample) |
| PT (1) | PT2461830E (enExample) |
| SG (2) | SG178095A1 (enExample) |
| SI (1) | SI2461830T1 (enExample) |
| SM (1) | SMT201400183B (enExample) |
| TW (1) | TWI469794B (enExample) |
| WO (1) | WO2011017249A1 (enExample) |
Families Citing this family (90)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101098854B (zh) | 2004-07-23 | 2012-12-05 | 恩多塞特公司 | 二价连接体及其轭合物 |
| WO2008112873A2 (en) | 2007-03-14 | 2008-09-18 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
| EP3569251A1 (en) | 2007-06-25 | 2019-11-20 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
| US9877965B2 (en) | 2007-06-25 | 2018-01-30 | Endocyte, Inc. | Vitamin receptor drug delivery conjugates for treating inflammation |
| CA2696627C (en) | 2007-08-17 | 2016-09-27 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| IT1394860B1 (it) * | 2009-07-22 | 2012-07-20 | Kemotech S R L | Composti farmaceutici |
| US8394922B2 (en) | 2009-08-03 | 2013-03-12 | Medarex, Inc. | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| US9951324B2 (en) | 2010-02-25 | 2018-04-24 | Purdue Research Foundation | PSMA binding ligand-linker conjugates and methods for using |
| JP2013534520A (ja) | 2010-06-08 | 2013-09-05 | ジェネンテック， インコーポレイテッド | システイン操作抗体及びコンジュゲート |
| ES2865449T3 (es) * | 2011-03-16 | 2021-10-15 | Hoffmann La Roche | Cromatografía de intercambio iónico con selectividad mejorada para la separación de monómeros, agregados y fragmentos polipeptídicos por modulación de la fase móvil |
| KR101972303B1 (ko) | 2011-06-10 | 2019-04-25 | 메르사나 테라퓨틱스, 인코포레이티드 | 단백질-중합체-약물 접합체 |
| WO2013126797A1 (en) | 2012-02-24 | 2013-08-29 | Purdue Research Foundation | Cholecystokinin b receptor targeting for imaging and therapy |
| US20140080175A1 (en) | 2012-03-29 | 2014-03-20 | Endocyte, Inc. | Processes for preparing tubulysin derivatives and conjugates thereof |
| EP2849797B1 (en) * | 2012-05-15 | 2019-12-18 | Concortis Biosystems, Corp | Drug-conjugates, conjugation methods, and uses thereof |
| PL3210627T3 (pl) | 2012-07-12 | 2023-04-17 | Hangzhou Dac Biotech Co., Ltd | Koniugaty zawierające cząsteczki wiążące się z komórką i środek cytotoksyczny |
| US11873281B2 (en) | 2012-07-12 | 2024-01-16 | Hangzhou Dac Biotech Co., Ltd. | Conjugates of cell binding molecules with cytotoxic agents |
| EP2708243A1 (en) | 2012-09-17 | 2014-03-19 | OntoChem GmbH | Receptor ligand linked cytotoxic molecules |
| HK1212618A1 (zh) | 2012-10-16 | 2016-06-17 | 恩多塞特公司 | 含有非天然氨基酸的藥物遞送綴合物以及其使用方法 |
| KR102354613B1 (ko) | 2012-11-15 | 2022-01-21 | 엔도사이트, 인코포레이티드 | Psma 발현 세포에 의해 야기되는 질병을 치료하기 위한 컨쥬게이트 |
| EP2922818B1 (en) | 2012-11-24 | 2018-09-05 | Hangzhou Dac Biotech Co., Ltd | Hydrophilic linkers and their uses for conjugation of drugs to cell binding molecules |
| EP2928504B1 (en) | 2012-12-10 | 2019-02-20 | Mersana Therapeutics, Inc. | Protein-polymer-drug conjugates |
| US9872918B2 (en) | 2012-12-12 | 2018-01-23 | Mersana Therapeutics, Inc. | Hydroxyl-polymer-drug-protein conjugates |
| SI2956173T1 (sl) * | 2013-02-14 | 2017-06-30 | Bristol-Myers Squibb Company | Spojine tubulizina, postopki pridobivanja in uporaba |
| US20140249315A1 (en) | 2013-03-01 | 2014-09-04 | Endocyte, Inc. | Processes for preparing tubulysins |
| MX368258B (es) | 2013-03-15 | 2019-09-25 | Zymeworks Inc | Compuestos citotoxicos y antimitoticos y metodos de uso de los mismos. |
| JP6171435B2 (ja) * | 2013-03-18 | 2017-08-02 | 富士通株式会社 | 半導体装置及びその製造方法、電源装置、高周波増幅器 |
| US10781259B2 (en) | 2013-06-06 | 2020-09-22 | Magenta Therapeutics, Inc. | Modified antibodies and related compounds, compositions, and methods of use |
| WO2015057585A1 (en) * | 2013-10-14 | 2015-04-23 | Regents Of The University Of Minnesota | Therapeutic compounds |
| HUE066137T2 (hu) | 2013-10-18 | 2024-07-28 | Novartis Ag | A prosztata-specifikus membrán antigén (PSMA) jelzett inhibitorai, alkalmazásuk képalkotásban és gyógyszerkészítmények prosztatarák kezelésére |
| JP6464166B2 (ja) | 2013-11-14 | 2019-02-06 | エンドサイト・インコーポレイテッドＥｎｄｏｃｙｔｅ， Ｉｎｃ． | 陽電子放出断層撮影用の化合物 |
| US20170168074A1 (en) | 2013-11-25 | 2017-06-15 | Ontochem Gmbh | Method for diagnosing G-protein coupled receptor-related diseases |
| CA2935077C (en) | 2013-12-27 | 2022-03-15 | Geoffrey C. Winters | Sulfonamide-containing linkage systems for drug conjugates |
| RU2714933C2 (ru) | 2013-12-27 | 2020-02-21 | Займворкс Инк. | Конъюгаты var2csa-лекарственное средство |
| US10183970B2 (en) | 2014-01-28 | 2019-01-22 | Tube Pharmaceuticals Gmbh | Cytotoxic tubulysin compounds for conjugation |
| AU2014384434B2 (en) | 2014-02-28 | 2016-11-03 | Hangzhou Dac Biotech Co., Ltd | Charged linkers and their uses for conjugation |
| WO2015135659A1 (en) | 2014-03-14 | 2015-09-17 | Ontochem Gmbh | Receptor ligand linked cytotoxic molecules |
| EP3647322B1 (en) | 2014-03-20 | 2021-10-20 | Bristol-Myers Squibb Company | Stabilized fibronectin based scaffold molecules |
| TW201625662A (zh) * | 2014-04-11 | 2016-07-16 | 麥迪紐有限責任公司 | 妥布賴森（ｔｕｂｕｌｙｓｉｎ）衍生物 |
| CA2951049C (en) * | 2014-06-03 | 2023-01-03 | Jiarui Biopharmaceuticals, Ltd. | Peptide-drug conjugates |
| CN104262455B (zh) * | 2014-08-22 | 2017-05-03 | 亚飞（上海）生物医药科技有限公司 | 肿瘤微环境靶向激活的紫杉醇衍生物及其制备和用途 |
| AU2015306574B2 (en) | 2014-08-22 | 2020-07-23 | Yafei Shanghai Biology Medicine Science & Technology Co. Ltd. | Specifically activated micromolecular target coupling body in tumor microenvironment and use thereof |
| SG10202006504QA (en) * | 2014-09-11 | 2020-08-28 | Seattle Genetics Inc | Targeted delivery of tertiary amine-containing drug substances |
| AU2015314826A1 (en) | 2014-09-12 | 2017-03-02 | Genentech, Inc. | Cysteine engineered antibodies and conjugates |
| KR102494557B1 (ko) | 2014-09-17 | 2023-02-02 | 자임워크스 비씨 인코포레이티드 | 세포독성 및 항유사분열성 화합물, 그리고 이를 이용하는 방법 |
| US10077287B2 (en) | 2014-11-10 | 2018-09-18 | Bristol-Myers Squibb Company | Tubulysin analogs and methods of making and use |
| DK3221363T3 (da) | 2014-11-21 | 2020-08-10 | Bristol Myers Squibb Co | Antistoffer mod cd73 og anvendelser deraf |
| HRP20201756T8 (hr) | 2014-11-21 | 2021-08-20 | Bristol-Myers Squibb Company | Antitijela koja sadrže modificirane regije teškog lanca |
| EP3224277B1 (en) | 2014-11-25 | 2020-08-26 | Bristol-Myers Squibb Company | Novel pd-l1 binding polypeptides for imaging |
| US10188759B2 (en) | 2015-01-07 | 2019-01-29 | Endocyte, Inc. | Conjugates for imaging |
| PE20180355A1 (es) | 2015-02-25 | 2018-02-21 | Univ Rice William M | Desacetoxitubulisina h y analogos de esta |
| US10676773B2 (en) | 2015-03-10 | 2020-06-09 | Bristol-Myers Squibb Company | Antibodies conjugatable by transglutaminase and conjugates made therefrom |
| LT3303396T (lt) | 2015-05-29 | 2023-01-10 | Bristol-Myers Squibb Company | Antikūnai prieš ox40 ir jų panaudojimo būdai |
| NZ739830A (en) | 2015-07-12 | 2021-12-24 | Hangzhou Dac Biotech Co Ltd | Bridge linkers for conjugation of cell-binding molecules |
| US9839687B2 (en) | 2015-07-15 | 2017-12-12 | Suzhou M-Conj Biotech Co., Ltd. | Acetylenedicarboxyl linkers and their uses in specific conjugation of a cell-binding molecule |
| ES2809125T3 (es) | 2015-09-23 | 2021-03-03 | Bristol Myers Squibb Co | Moléculas de armazón a base de fibronectina de unión a glipicano-3 |
| TWI678364B (zh) * | 2015-09-24 | 2019-12-01 | 南韓商Ｌｇ化學股份有限公司 | 化合物及含有該化合物的有機發光裝置 |
| TWI660741B (zh) | 2015-11-03 | 2019-06-01 | 財團法人工業技術研究院 | 抗體藥物複合物及其製造方法 |
| US11793880B2 (en) | 2015-12-04 | 2023-10-24 | Seagen Inc. | Conjugates of quaternized tubulysin compounds |
| SG11201804268RA (en) | 2015-12-04 | 2018-06-28 | Seattle Genetics Inc | Conjugates of quaternized tubulysin compounds |
| WO2017112624A1 (en) | 2015-12-21 | 2017-06-29 | Bristol-Myers Squibb Company | Variant antibodies for site-specific conjugation |
| CA3012960A1 (en) | 2016-02-01 | 2017-08-10 | Pfizer Inc. | Tubulysin analogs and methods for their preparation |
| KR20180118725A (ko) | 2016-03-04 | 2018-10-31 | 브리스톨-마이어스 스큅 컴퍼니 | 항-cd73 항체와의 조합 요법 |
| CN105664134B (zh) * | 2016-03-13 | 2019-04-26 | 浙江药苑生物科技有限公司 | 一种用于治疗骨癌的药物组合物 |
| US20170326249A1 (en) | 2016-05-10 | 2017-11-16 | Bristol-Myers Squibb Company | Antibody-drug conjugate of an anti-glypican-3 antibody and a tubulysin analog, preparation and uses |
| WO2017196598A1 (en) | 2016-05-10 | 2017-11-16 | Bristol-Myers Squibb Company | Antibody-drug conjugates of tubulysin analogs with enhanced stability |
| US10106560B2 (en) | 2016-06-16 | 2018-10-23 | Bristol-Myers Squibb Company | Process and intermediates for making tubulysin analogs |
| KR102493853B1 (ko) | 2016-08-19 | 2023-01-30 | 브리스톨-마이어스 스큅 컴퍼니 | 세코-시클로프로파피롤로인돌 화합물, 그의 항체-약물 접합체, 및 제조 및 사용 방법 |
| US20190218294A1 (en) | 2016-09-09 | 2019-07-18 | Bristol-Myers Squibb Company | Use of an anti-pd-1 antibody in combination with an anti-mesothelin antibody in cancer treatment |
| US10517958B2 (en) | 2016-10-04 | 2019-12-31 | Zymeworks Inc. | Compositions and methods for the treatment of platinum-drug resistant cancer |
| WO2018075842A1 (en) | 2016-10-20 | 2018-04-26 | Bristol-Myers Squibb Company | Condensed benzodiazepine derivatives and conjugates made therefrom |
| KR102345175B1 (ko) | 2016-11-14 | 2021-12-31 | 항저우 디에이씨 바이오테크 씨오, 엘티디 | 결합 링커, 그러한 결합 링커를 함유하는 세포 결합 분자-약물 결합체, 링커를 갖는 그러한 결합체의 제조 및 사용 |
| JP6585650B2 (ja) * | 2017-03-23 | 2019-10-02 | ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド | 細胞毒性剤と細胞結合受容体との共役体 |
| IL270596B1 (en) | 2017-05-25 | 2025-09-01 | Bristol Myers Squibb Co | Antibodies comprising modified heavy constant region for use in treating cancer |
| US11274124B2 (en) | 2017-11-29 | 2022-03-15 | William Marsh Rice University | Tubulysin analogues as anticancer agents and payloads for antibody-drug conjugates and methods of treatment therewith |
| CA3097381A1 (en) | 2018-04-17 | 2019-10-24 | Endocyte, Inc. | Methods of treating cancer |
| US11485741B2 (en) | 2018-04-24 | 2022-11-01 | Bristol-Myers Squibb Company | Macrocyclic toll-like receptor 7 (TLR7) agonists |
| EP3801629A1 (en) | 2018-05-29 | 2021-04-14 | Bristol-Myers Squibb Company | Modified self-immolating moieties for use in prodrugs and conjugates and methods of using and making |
| US11020490B2 (en) | 2018-06-22 | 2021-06-01 | Bristol-Myers Squibb Company | Antibody-drug conjugate with a tubulysin analog warhead having a stabilized acetate group in the TUV subunit |
| KR20210096167A (ko) | 2018-11-28 | 2021-08-04 | 브리스톨-마이어스 스큅 컴퍼니 | 변형된 중쇄 불변 영역을 포함하는 항체 |
| HUE062089T2 (hu) | 2018-11-30 | 2023-09-28 | Rao Naik Chetana | Antitest, amely tartalmaz glutamintartalmú könnyû lánc C-terminális meghosszabbítást, annak konjugátumai, és eljárások és felhasználások |
| US12478686B2 (en) | 2018-12-12 | 2025-11-25 | Bristol-Myers Squibb Company | Antibodies modified for transglutaminase conjugation, conjugates thereof, and methods and uses |
| EP3898651A2 (en) | 2018-12-21 | 2021-10-27 | Regeneron Pharmaceuticals, Inc. | Tubulysins and protein-tubulysin conjugates |
| CN120097930A (zh) | 2019-05-20 | 2025-06-06 | 因多塞特股份有限公司 | 制备psma缀合物的方法 |
| JP6842127B2 (ja) * | 2019-05-22 | 2021-03-17 | ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド | 細胞毒性剤と細胞結合受容体との共役体 |
| CA3145050A1 (en) | 2019-06-29 | 2021-01-07 | Robert Zhao | Conjugates of tubulysin derivatives and cell binding molecules and methods of making |
| US20240377413A1 (en) | 2019-09-16 | 2024-11-14 | Bristol-Myers Squibb Company | Dual capture method for analysis of antibody-drug conjugates |
| CN113387829B (zh) * | 2020-03-13 | 2023-04-07 | 凯特立斯（深圳）科技有限公司 | 一种沙库必曲的制备方法 |
| JP2023533218A (ja) * | 2020-06-24 | 2023-08-02 | レゲネロン ファーマシューティカルス，インコーポレーテッド | ツブリシン及びタンパク質－ツブリシンコンジュゲート |
| JP7044419B2 (ja) * | 2021-02-04 | 2022-03-30 | ハンヂョウ ディーエイシー バイオテック カンパニー リミテッド | 細胞毒性剤と細胞結合受容体との共役体 |
| CA3236930A1 (en) | 2021-11-03 | 2022-04-21 | Hangzhou Dac Biotech Co., Ltd. | Specific conjugation of an antibody |
Family Cites Families (73)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1981001145A1 (en) | 1979-10-18 | 1981-04-30 | Univ Illinois | Hydrolytic enzyme-activatible pro-drugs |
| US4475196A (en) | 1981-03-06 | 1984-10-02 | Zor Clair G | Instrument for locating faults in aircraft passenger reading light and attendant call control system |
| US4447233A (en) | 1981-04-10 | 1984-05-08 | Parker-Hannifin Corporation | Medication infusion pump |
| US5144011A (en) | 1981-06-26 | 1992-09-01 | Boston University | Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers |
| US4631190A (en) | 1981-06-26 | 1986-12-23 | Shen Wei C | Acidity-sensitive spacer molecule to control the release of pharmaceuticals from molecular carriers |
| US4439196A (en) | 1982-03-18 | 1984-03-27 | Merck & Co., Inc. | Osmotic drug delivery system |
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| US4447224A (en) | 1982-09-20 | 1984-05-08 | Infusaid Corporation | Variable flow implantable infusion apparatus |
| US4487603A (en) | 1982-11-26 | 1984-12-11 | Cordis Corporation | Implantable microinfusion pump system |
| US4486194A (en) | 1983-06-08 | 1984-12-04 | James Ferrara | Therapeutic device for administering medicaments through the skin |
| US4698420A (en) | 1985-02-25 | 1987-10-06 | Xoma Corporation | Antibody hybrid molecules and process for their preparation |
| US4596556A (en) | 1985-03-25 | 1986-06-24 | Bioject, Inc. | Hypodermic injection apparatus |
| US5374548A (en) | 1986-05-02 | 1994-12-20 | Genentech, Inc. | Methods and compositions for the attachment of proteins to liposomes using a glycophospholipid anchor |
| MX9203291A (es) | 1985-06-26 | 1992-08-01 | Liposome Co Inc | Metodo para acoplamiento de liposomas. |
| US4941880A (en) | 1987-06-19 | 1990-07-17 | Bioject, Inc. | Pre-filled ampule and non-invasive hypodermic injection device assembly |
| US4790824A (en) | 1987-06-19 | 1988-12-13 | Bioject, Inc. | Non-invasive hypodermic injection device |
| US5108921A (en) | 1989-04-03 | 1992-04-28 | Purdue Research Foundation | Method for enhanced transmembrane transport of exogenous molecules |
| US5312335A (en) | 1989-11-09 | 1994-05-17 | Bioject Inc. | Needleless hypodermic injection device |
| US5064413A (en) | 1989-11-09 | 1991-11-12 | Bioject, Inc. | Needleless hypodermic injection device |
| US5383851A (en) | 1992-07-24 | 1995-01-24 | Bioject Inc. | Needleless hypodermic injection device |
| US6214345B1 (en) | 1993-05-14 | 2001-04-10 | Bristol-Myers Squibb Co. | Lysosomal enzyme-cleavable antitumor drug conjugates |
| TW420681B (en) | 1995-12-08 | 2001-02-01 | Lederle Japan Ltd | Carbapenem-3-carboxylic acid ester derivatives |
| DE19638870B4 (de) | 1996-09-23 | 2009-05-14 | Helmholtz-Zentrum für Infektionsforschung GmbH | Tubulysine, Verfahren zu ihrer Gewinnung und sie enthaltende Mittel |
| US7214487B2 (en) | 1998-06-26 | 2007-05-08 | Sunesis Pharmaceuticals, Inc. | Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates |
| EP1212422B1 (en) | 1999-08-24 | 2007-02-21 | Medarex, Inc. | Human ctla-4 antibodies and their uses |
| DE10008089A1 (de) | 2000-02-22 | 2001-10-31 | Biotechnolog Forschung Gmbh | Syntheseverfahren zur Herstellung von Tubulysinen |
| PE20020908A1 (es) | 2001-03-21 | 2002-10-26 | Cell Therapeutics Inc | Produccion recombinante de polimeros polianionicos y uso de de los mismos |
| US6989452B2 (en) | 2001-05-31 | 2006-01-24 | Medarex, Inc. | Disulfide prodrugs and linkers and stabilizers useful therefor |
| US7091186B2 (en) | 2001-09-24 | 2006-08-15 | Seattle Genetics, Inc. | p-Amidobenzylethers in drug delivery agents |
| WO2003059282A2 (en) | 2002-01-09 | 2003-07-24 | Medarex, Inc. | Human monoclonal antibodies against cd30 |
| WO2004005327A1 (de) | 2002-07-09 | 2004-01-15 | Morphochem Ag Komb Chemie | Neue tubulysinanaloga |
| WO2004005326A2 (de) | 2002-07-09 | 2004-01-15 | Morphochem Aktiengellschaft Fu | Tubulysinkonjugate |
| DE10241152A1 (de) | 2002-09-05 | 2004-03-18 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Tubulysin-Biosynthese-Gene |
| FR2845630B1 (fr) * | 2002-10-09 | 2005-09-30 | Helitest Ags | Dispositif de demasticage, notamment pour la refection de joints dans des structures de reservoirs d'aeronefs et container d'intervention |
| DE10254439A1 (de) * | 2002-11-21 | 2004-06-03 | GESELLSCHAFT FüR BIOTECHNOLOGISCHE FORSCHUNG MBH (GBF) | Tubulysine, Herstellungsverfahren und Tubulysin-Mittel |
| EP1613274B1 (en) | 2003-04-15 | 2010-03-03 | GlaxoSmithKline LLC | Human il-18 substitution mutants and their conjugates |
| MXPA06000798A (es) | 2003-07-22 | 2006-04-07 | Schering Ag | Anticuerpos de rg1 y usos de los mismos. |
| AU2005216251B2 (en) | 2004-02-23 | 2011-03-10 | Genentech, Inc. | Heterocyclic self-immolative linkers and conjugates |
| RU2402548C2 (ru) | 2004-05-19 | 2010-10-27 | Медарекс, Инк. | Химические линкеры и их конъюгаты |
| MXPA06013413A (es) | 2004-05-19 | 2007-01-23 | Medarex Inc | Enlazadores quimicos y conjugados de los mismos. |
| US7541330B2 (en) | 2004-06-15 | 2009-06-02 | Kosan Biosciences Incorporated | Conjugates with reduced adverse systemic effects |
| DE102004030227A1 (de) | 2004-06-23 | 2006-01-26 | Dömling, Alexander, Dr. | Wirkstoffe mit antiangiogenetischen Eigenschaften |
| ES2579805T3 (es) | 2004-09-23 | 2016-08-16 | Genentech, Inc. | Anticuerpos y conjugados modificados por ingeniería genética con cisteína |
| JP2008529556A (ja) | 2005-02-18 | 2008-08-07 | メダレックス， インク． | 前立腺特異的膜抗原（ｐｓｍａ）に対するヒトモノクローナル抗体 |
| US7714016B2 (en) | 2005-04-08 | 2010-05-11 | Medarex, Inc. | Cytotoxic compounds and conjugates with cleavable substrates |
| CN109485727A (zh) | 2005-05-09 | 2019-03-19 | 小野药品工业株式会社 | 程序性死亡-1(pd-1)的人单克隆抗体及使用抗pd-1抗体来治疗癌症的方法 |
| JP5215180B2 (ja) | 2005-06-20 | 2013-06-19 | メダレックス インコーポレーティッド | Ｃｄ１９抗体およびその使用法 |
| BRPI0615354A2 (pt) | 2005-08-19 | 2011-05-17 | Endocyte Inc | conjugado de liberação de fármaco de ligação de receptor, composição farmacêutica que o compreende, bem como seu uso |
| JP5290756B2 (ja) | 2005-09-26 | 2013-09-18 | メダレックス インコーポレイテッド | 抗体−薬剤コンジュゲート及びその使用 |
| CA2623236A1 (en) | 2005-09-26 | 2007-04-05 | Medarex, Inc. | Human monoclonal antibodies to cd70 |
| EP1940789B1 (en) | 2005-10-26 | 2011-11-23 | Medarex, Inc. | Methods and compounds for preparing cc-1065 analogs |
| WO2007059404A2 (en) | 2005-11-10 | 2007-05-24 | Medarex, Inc. | Duocarmycin derivatives as novel cytotoxic compounds and conjugates |
| CA2630483C (en) | 2005-12-08 | 2015-05-19 | Medarex, Inc. | Human monoclonal antibodies to o8e |
| EA017812B1 (ru) | 2005-12-08 | 2013-03-29 | Медарекс, Инк. | Выделенное моноклональное антитело или его антигенсвязывающий участок, которые связываются с протеинтирозинкиназой 7 ( ptk7) человека, и их применение |
| CN103172743B (zh) | 2006-12-01 | 2015-04-08 | 梅达雷克斯有限责任公司 | 结合cd22的人抗体及其用途 |
| US20100150950A1 (en) | 2006-12-14 | 2010-06-17 | Medarex, Inc. | Human antibodies that bind cd70 and uses thereof |
| UY30776A1 (es) | 2006-12-21 | 2008-07-03 | Medarex Inc | Anticuerpos cd44 |
| TWI412367B (zh) | 2006-12-28 | 2013-10-21 | Medarex Llc | 化學鏈接劑與可裂解基質以及其之綴合物 |
| JP2010516625A (ja) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス， インコーポレイテッド | 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート |
| JP2010519310A (ja) | 2007-02-21 | 2010-06-03 | メダレックス インコーポレイテッド | 単一のアミノ酸を有する化学リンカーおよびその複合体 |
| WO2008106080A2 (en) | 2007-02-27 | 2008-09-04 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Synthesis of desacetoxytubulysin h and analogs thereof |
| WO2008112873A2 (en) | 2007-03-14 | 2008-09-18 | Endocyte, Inc. | Binding ligand linked drug delivery conjugates of tubulysins |
| ES2463693T3 (es) | 2007-05-10 | 2014-05-29 | R & D Biopharmaceuticals Gmbh | Derivados de tubulisina |
| EP3569251A1 (en) | 2007-06-25 | 2019-11-20 | Endocyte, Inc. | Conjugates containing hydrophilic spacer linkers |
| US7387981B1 (en) | 2007-06-28 | 2008-06-17 | Lyondell Chemical Technology, L.P. | Direct epoxidation catalyst and process |
| US20110263650A1 (en) | 2007-07-20 | 2011-10-27 | Helmholtz-Zentrum Für Infektions-Forschung Gmbh | Tubulysin D Analogues |
| CA2696627C (en) | 2007-08-17 | 2016-09-27 | Purdue Research Foundation | Psma binding ligand-linker conjugates and methods for using |
| EP2185188B1 (en) | 2007-08-22 | 2014-08-06 | Medarex, L.L.C. | Site-specific attachment of drugs or other agents to engineered antibodies with c-terminal extensions |
| KR101554753B1 (ko) | 2007-10-01 | 2015-09-22 | 브리스톨-마이어스 스큅 컴퍼니 | 메소텔린에 결합하는 인간 항체 및 이의 용도 |
| WO2009055562A1 (en) | 2007-10-25 | 2009-04-30 | Endocyte, Inc. | Tubulysins and processes for preparing |
| EP2174947A1 (en) | 2008-09-25 | 2010-04-14 | Universität des Saarlandes | Bioactive pre-tubulysins and use thereof |
| US8394922B2 (en) | 2009-08-03 | 2013-03-12 | Medarex, Inc. | Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| US9163060B2 (en) * | 2009-11-12 | 2015-10-20 | R&D Biopharmaceuticals Gmbh | Tubulin inhibitors |
-
2010
- 2010-07-29 US US12/846,493 patent/US8394922B2/en active Active
- 2010-08-02 BR BR112012002615-1A patent/BR112012002615A2/pt not_active Application Discontinuation
- 2010-08-02 PE PE2012000147A patent/PE20121087A1/es active IP Right Grant
- 2010-08-02 CN CN201080045031.9A patent/CN102725001B/zh not_active Expired - Fee Related
- 2010-08-02 JP JP2012523678A patent/JP5859964B2/ja not_active Expired - Fee Related
- 2010-08-02 MX MX2012001665A patent/MX2012001665A/es active IP Right Grant
- 2010-08-02 DK DK10739817.4T patent/DK2461830T3/en active
- 2010-08-02 PL PL10739817T patent/PL2461830T3/pl unknown
- 2010-08-02 AU AU2010279674A patent/AU2010279674B2/en not_active Ceased
- 2010-08-02 PT PT107398174T patent/PT2461830E/pt unknown
- 2010-08-02 IN IN860DEN2012 patent/IN2012DN00860A/en unknown
- 2010-08-02 EP EP10739817.4A patent/EP2461830B1/en active Active
- 2010-08-02 HU HUE10739817A patent/HUE026997T2/en unknown
- 2010-08-02 WO PCT/US2010/044078 patent/WO2011017249A1/en not_active Ceased
- 2010-08-02 ES ES10739817.4T patent/ES2525351T3/es active Active
- 2010-08-02 CA CA2770042A patent/CA2770042C/en not_active Expired - Fee Related
- 2010-08-02 KR KR1020127005701A patent/KR101759359B1/ko not_active Expired - Fee Related
- 2010-08-02 SG SG2012005054A patent/SG178095A1/en unknown
- 2010-08-02 SI SI201030809T patent/SI2461830T1/sl unknown
- 2010-08-02 HR HRP20140976AT patent/HRP20140976T1/hr unknown
- 2010-08-02 SG SG10201503332XA patent/SG10201503332XA/en unknown
- 2010-08-02 NZ NZ597985A patent/NZ597985A/xx not_active IP Right Cessation
- 2010-08-02 CN CN201410720841.XA patent/CN104592351A/zh active Pending
- 2010-08-02 EA EA201270242A patent/EA022288B1/ru not_active IP Right Cessation
- 2010-08-03 AR ARP100102856A patent/AR077701A1/es active IP Right Grant
- 2010-08-03 TW TW99125854A patent/TWI469794B/zh not_active IP Right Cessation
-
2012
- 2012-01-24 IL IL217717A patent/IL217717A/en active IP Right Grant
- 2012-02-03 CL CL2012000302A patent/CL2012000302A1/es unknown
- 2012-02-28 CO CO12034850A patent/CO6501196A2/es active IP Right Grant
-
2013
- 2013-01-29 US US13/752,619 patent/US8802632B2/en active Active
- 2013-01-29 US US13/752,664 patent/US8772542B2/en active Active
- 2013-01-29 US US13/752,721 patent/US8772543B2/en active Active
-
2014
- 2014-07-07 US US14/324,480 patent/US9226974B2/en active Active
- 2014-12-11 SM SM201400183T patent/SMT201400183B/xx unknown
-
2015
- 2015-11-12 US US14/939,547 patent/US9580467B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013501055A5 (enExample) | ||
| CN100420672C (zh) | 选择性抑制cox-2并衍生于吲哚链烷醇的新酯以及衍生于吲哚链烷胺的新酰胺 | |
| US10280183B2 (en) | Therapeutic agent for treating tumors | |
| JP2008522981A5 (enExample) | ||
| JP5542436B2 (ja) | 非常に速い皮膚透過率を有するジクロフェナクの正荷電水溶性プロドラッグ | |
| HRP20140976T1 (hr) | Antiproliferativne tvari, njihovi konjugati, metode za njih i njihove uporabe | |
| KR930703305A (ko) | 5-헤테로일 인돌 유도체 | |
| HUP0301427A2 (hu) | Fotokemoterápiában alkalmazható fotoszenzitizáló, 5-aminolevulinsavészterek azokat tartalmazó gyógyszerkészítmények és alkalmazásuk | |
| CA2159546A1 (en) | Cycloalkano-indole and -azaindole derivatives | |
| US11420949B2 (en) | Cystine diamide analogs for the prevention of cystine stone formation in cystinuria | |
| CA2683383A1 (en) | Bridged polycyclic compound based compositions for the inhibition and amelioration of disease | |
| TWI326687B (en) | Amide prodrug of gemcitabine, compositions and use thereof | |
| CA3030907A1 (en) | Chelated psma inhibitors | |
| EP2197494A2 (en) | Functionalized nanoparticles for the inhibition of selectin-mediated cell adhesion | |
| JP2004529172A5 (enExample) | ||
| JP2025521241A (ja) | ビフェニル系化合物、医薬組成物およびその調製方法と使用 | |
| ES2449569T3 (es) | Sal de un antagonista de CD80 | |
| ES2519476T3 (es) | Composiciones administrables | |
| JP2004538278A5 (enExample) | ||
| CA2480560C (en) | .kappa.-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative | |
| CA2671816A1 (en) | Salts of imidazole-5-carboxylic acid derivatives, a method for preparing same and pharmaceutical compositions comprising same | |
| CN105199095B (zh) | 一种基于巯基物质检测的两亲性分子探针及其合成方法 | |
| CN108715579A (zh) | 一种2-（α羟基戊基）苯甲酸的有机胺酯衍生物药物 | |
| JP2009534449A (ja) | １，４−ナフトキノン系化合物、該化合物を含んでなる組成物、およびこれらの化合物の抗がん剤としての使用 | |
| JP4296345B2 (ja) | ２−フェニルベンゾチアゾリン誘導体 |